RxDoctor Payments Data

Patrick Rask, MD

Interventional Pain Medicine · Corvallis, ORNPI 1427188309

Payments from drug & device makers

What this record shows

29 manufacturers reported payments, led by Medtronic at 28.1% of the total. Reporting peaked in 2022 at $1,850 and has fallen 85.1% since, to $276 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in OR, where the typical reported total is $8,094.

$6,990in general payments, 2019–2025

Across 198 payments — averaging $35.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Relievant Medsystems, Inc.$968
  • Boston Scientific$950
  • Abbott$790
  • Nalu Medical, Inc.$672
  • Amgen$244
  • plus $1K from 23 others

What the payments were for

  • Travel & lodging$2,86241%
  • Food & beverage$4,12859%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,990 in reported general payments places this provider in the 45th percentile of 22 interventional pain medicine providers in Oregon.

See all interventional pain medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$254,524
Medicare patients
606
Services billed
10,808

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin42$876
Celecoxib81$789
Gabapentin67$740
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen43$668
Baclofen38$415
Oxycodone Hcl37$343
Tizanidine Hcl50$312
Methocarbamol14$225
Duloxetine Hcl18$200
Doxepin Hcl13$178
Diazepam185$167
Cephalexin21$108
Topiramate17$95
Trazodone Hcl15$94
Meloxicam22$74

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Corvallis

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →